FDA.reportPublic FDA data

VITRAKVI 20 MG in 1 mL Oral Solution

RxCUI
2105653
RxNorm name
VITRAKVI 20 MG in 1 mL Oral Solution
Display name
VITRAKVI 20 MG in 1 mL Oral Solution
Full name
VITRAKVI 20 MG in 1 mL Oral Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VITRAKVILAROTRECTINIBBayer HealthCare Pharmaceuticals Inc.0c8ca614-58b2-4aa4-83d3-0387a8f782fd2026-05-22Warnings, Adverse reactionsExact identifier
rxcui: 2105653
VITRAKVILAROTRECTINIBLoxo Oncology, Inc.9525f887-a055-4e33-8e92-898d42828cd12018-12-05Warnings, Adverse reactionsExact identifier
rxcui: 2105653

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0c8ca614-58b2-4aa4-83d3-0387a8f782fdVITRAKVI 20 MG in 1 mL Oral Solution [PSN] · larotrectinib 20 MG/ML Oral Solution [Vitrakvi] [SBD] · Vitrakvi 20 MG (as 24.6 MG larotrectinib sulfate) per 1 mL Oral Solution [SY] · Vitrakvi 20 MG per 1 mL Oral Solution [SY] · Vitrakvi 20 MG/ML Oral Solution [SY]521These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 201820260522
9525f887-a055-4e33-8e92-898d42828cd1VITRAKVI 20 MG in 1 mL Oral Solution [PSN] · larotrectinib 20 MG/ML Oral Solution [Vitrakvi] [SBD] · Vitrakvi 20 MG (as 24.6 MG larotrectinib sulfate) per 1 mL Oral Solution [SY] · Vitrakvi 20 MG per 1 mL Oral Solution [SY] · Vitrakvi 20 MG/ML Oral Solution [SY]53These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 201820181205